Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 3 studies | 26% ± 8% |
Insufficient scRNA-seq data for expression of CCDC62 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 84.48 | 2626 / 2642 | 25% | 0.34 | 179 / 705 |
spleen | 100% | 83.71 | 241 / 241 | 0% | 0 | 0 / 0 |
muscle | 99% | 82.76 | 798 / 803 | 0% | 0 | 0 / 0 |
breast | 97% | 39.64 | 446 / 459 | 2% | 0.03 | 21 / 1118 |
uterus | 96% | 28.05 | 164 / 170 | 1% | 0.02 | 6 / 459 |
prostate | 97% | 38.09 | 237 / 245 | 0% | 0.00 | 1 / 502 |
adipose | 96% | 38.18 | 1157 / 1204 | 0% | 0 | 0 / 0 |
skin | 93% | 30.68 | 1680 / 1809 | 2% | 0.02 | 9 / 472 |
bladder | 90% | 18.05 | 19 / 21 | 2% | 0.03 | 11 / 504 |
lung | 87% | 24.69 | 504 / 578 | 2% | 0.02 | 18 / 1155 |
thymus | 81% | 20.51 | 529 / 653 | 4% | 0.05 | 25 / 605 |
intestine | 84% | 22.88 | 810 / 966 | 1% | 0.01 | 4 / 527 |
ovary | 83% | 21.70 | 149 / 180 | 1% | 0.01 | 3 / 430 |
blood vessel | 82% | 20.04 | 1091 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 80% | 18.86 | 207 / 258 | 1% | 0.04 | 3 / 230 |
stomach | 74% | 15.53 | 267 / 359 | 3% | 0.05 | 8 / 286 |
pancreas | 74% | 16.34 | 242 / 328 | 3% | 0.11 | 5 / 178 |
kidney | 73% | 15.26 | 65 / 89 | 1% | 0.02 | 10 / 901 |
heart | 74% | 18.27 | 635 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 71% | 27.07 | 664 / 929 | 0% | 0 | 0 / 0 |
esophagus | 67% | 14.51 | 974 / 1445 | 2% | 0.05 | 4 / 183 |
liver | 43% | 9.00 | 98 / 226 | 0% | 0.00 | 1 / 406 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071392 | Biological process | cellular response to estradiol stimulus |
GO_0001835 | Biological process | blastocyst hatching |
GO_0007286 | Biological process | spermatid development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0001669 | Cellular component | acrosomal vesicle |
GO_0005634 | Cellular component | nucleus |
GO_0030374 | Molecular function | nuclear receptor coactivator activity |
GO_0005515 | Molecular function | protein binding |
GO_0030331 | Molecular function | nuclear estrogen receptor binding |
Gene name | CCDC62 |
Protein name | Coiled-coil domain-containing protein 62 (Protein TSP-NY) (Protein aaa) Coiled-coil domain containing 62 |
Synonyms | hCG_2015662 |
Description | FUNCTION: Nuclear receptor coactivator that can enhance preferentially estrogen receptors ESR1 and ESR2 transactivation. Modulates also progesterone/PGR, glucocorticoid/NR3C1 and androgen/AR receptors transactivation, although at lower level; little effect on vitamin D receptor/VDR. Required for normal spermiogenesis. It probably plays a role in acrosome formation (By similarity). . |
Accessions | Q6P9F0 ENST00000253079.11 [Q6P9F0-1] ENST00000539171.1 F5H0F1 ENST00000341952.8 [Q6P9F0-2] ENST00000392440.3 A0A024RBT8 ENST00000392441.8 [Q6P9F0-2] ENST00000537566.5 [Q6P9F0-3] |